| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.574 | 26.265 | 34.354 | 39.411 | 34.320 | 29.800 | 34.355 | 46.568 | 43.402 | 65.597 |
| Total Income - EUR | 27.781 | 27.117 | 34.740 | 39.539 | 34.752 | 32.114 | 35.588 | 46.670 | 43.473 | 67.518 |
| Total Expenses - EUR | 19.986 | 19.254 | 27.506 | 29.235 | 28.019 | 25.103 | 29.790 | 31.163 | 33.047 | 38.842 |
| Gross Profit/Loss - EUR | 7.795 | 7.863 | 7.234 | 10.304 | 6.733 | 7.011 | 5.798 | 15.507 | 10.426 | 28.676 |
| Net Profit/Loss - EUR | 6.993 | 7.593 | 6.889 | 9.910 | 6.387 | 6.712 | 5.478 | 15.050 | 10.022 | 26.865 |
| Employees | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dexign Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.186 | 714 | 1.433 | 1.541 | 948 | 19.376 | 14.891 | 9.030 | 3.657 | 2.358 |
| Current Assets | 15.290 | 16.089 | 15.556 | 19.364 | 21.658 | 7.753 | 12.095 | 16.060 | 15.812 | 34.318 |
| Inventories | 90 | 89 | 83 | 77 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 6.133 | 6.116 | 4.908 | 3.126 | 5.340 | 3.360 | 3.452 | 12.198 | 3.630 | 5.265 |
| Cash | 9.067 | 9.883 | 10.565 | 16.161 | 16.317 | 4.393 | 8.644 | 3.863 | 12.183 | 29.053 |
| Shareholders Funds | 13.847 | 14.377 | 13.558 | 18.605 | 19.340 | 25.686 | 24.934 | 21.228 | 16.428 | 33.612 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.636 | 2.629 | 3.620 | 2.409 | 3.381 | 1.748 | 2.305 | 4.113 | 3.436 | 3.478 |
| Income in Advance | 142 | 228 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7412 - 7412" | |||||||||
| CAEN Financial Year |
7410
|
|||||||||
Comments - Dexign Srl